4.8 Article

Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells

Journal

ONCOGENE
Volume 37, Issue 37, Pages 5054-5065

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41388-018-0343-8

Keywords

-

Funding

  1. National Cancer Institute [CA206564, R01 CA138833]
  2. Department of Veterans Affairs [BX002115]
  3. Vanderbilt Ingram Cancer Center [P30 CA68485]
  4. Vanderbilt Digestive Disease Research Center [DK058404]

Ask authors/readers for more resources

Infection with Helicobacter pylori is one of the strongest risk factors for development of gastric cancer. Although these bacteria infect approximately half of the world's population, only a small fraction of infected individuals develops gastric malignancies. Interactions between host and bacterial virulence factors are complex and interrelated, making it difficult to elucidate specific processes associated with H. pylori-induced tumorigenesis. In this study, we found that H. pylori inhibits p14ARF tumor suppressor by inducing its degradation. This effect was found to be strain-specific. Downregulation of p14ARF induced by H. pylori leads to inhibition of autophagy in a p53-independent manner in infected cells. We identified TRIP12 protein as E3 ubiquitin ligase that is upregulated by H. pylori, inducing ubiquitination and subsequent degradation of p14ARF protein. Using isogenic H. pylori mutants, we found that induction of TRIP12 is mediated by bacterial virulence factor CagA. Increased expression of TRIP12 protein was found in infected gastric epithelial cells in vitro and human gastric mucosa of H. pylori-infected individuals. In conclusion, our data demonstrate a new mechanism of ARF inhibition that may affect host-bacteria interactions and facilitate tumorigenic transformation in the stomach.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments

Jennifer M. Noto, Abha Chopra, John T. Loh, Judith Romero-Gallo, M. Blanca Piazuelo, Mark Watson, Shay Leary, Amber C. Beckett, Keith T. Wilson, Timothy L. Cover, Simon Mallal, Dawn A. Israel, Richard M. Peek

Article Materials Science, Biomaterials

Syntheses of gold nanoparticles and their impact on the cell cycle in breast cancer cells subjected to megavoltage X-ray irradiation

Nikolina Hanzic, Angela Horvat, Juraj Bibic, Klaus Unfried, Tanja Jurkin, Goran Drazic, Inga Marijanovic, Neda Slade, Marijan Gotic

MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)

Article Multidisciplinary Sciences

Helicobacter pylori genetic diversification in the Mongolian gerbil model

Amber C. Beckett, John T. Loh, Abha Chopra, Shay Leary, Aung Soe Lin, Wyatt J. McDonnell, Beverly R. E. A. Dixon, Jennifer M. Noto, Dawn A. Israel, Richard M. Peek, Simon Mallal, Holly M. Scott Algood, Timothy L. Cover

PEERJ (2018)

Article Biochemical Research Methods

Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression

Jennifer M. Noto, Kristie L. Rose, Amanda J. Hachey, Alberto G. Delgado, Judith Romero-Gallo, Lydia E. Wroblewski, Barbara G. Schneider, Shailja C. Shah, Timothy L. Cover, Keith T. Wilson, Dawn A. Israel, Juan Carlos Roa, Kevin L. Schey, Yana Zavros, M. Blanca Piazuelo, Richard M. Peek

MOLECULAR & CELLULAR PROTEOMICS (2019)

Article Microbiology

Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype

Jennifer M. Noto, Joseph P. Zackular, Matthew G. Varga, Alberto Delgado, Judith Romero-Gallo, Matthew B. Scholz, M. Blanca Piazuelo, Eric P. Skaar, Richard M. Peek

Editorial Material Gastroenterology & Hepatology

RNF43: A Biomarker With Potential Ramifications for Therapeutic Intervention in Gastric Cancer

Jennifer M. Noto, Richard M. Peek

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor

Jinghua Peng, Balamurugan Ramatchandirin, Yu Wang, Alexia Pearah, Kopperuncholan Namachivayam, Risa M. Wolf, Kimberley Steele, Krishnan MohanKumar, Liqing Yu, Shaodong Guo, Morris F. White, Akhil Maheshwari, Ling He

Summary: This study reveals the molecular mechanism of how C646, a specific inhibitor of P300 acetyltransferase, improves insulin signaling. The researchers found that P300 levels were increased in the liver hepatocytes of obese patients, and that inhibition of P300 activity by C646 promoted insulin signaling by enhancing IRS1/2 membrane translocation and promoting IR beta interaction with IRS1/2. These findings have important implications for the treatment of obesity and diabetes.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Cell Biology

Reciprocal regulation of p21 and Chk1 controls the cyclin D1-RB pathway to mediate senescence onset after G2 arrest

Gerald Lossaint, Andela Horvat, Veronique Gire, Katarina Bacevic, Karim Mrouj, Fabienne Charrier-Savournin, Virginie Georget, Daniel Fisher, Vjekoslav Dulic

Summary: The balance between p21 and Chk1 controls cyclin D-CDK activity during cell cycle arrest, with p21 activating RB in non-transformed cells and Chk1 maintaining its activity in cancer cells. The compromised G2 exit in cancer cells is associated with sustained Chk1 activity, delayed p21 induction, untimely cyclin E1 re-expression, and genome reduplication.

JOURNAL OF CELL SCIENCE (2022)

Article Gastroenterology & Hepatology

Helicobacter pylori actively suppresses innate immune nucleic acid receptors

Samuel D. R. Dooyema, Jennifer M. Noto, Lydia E. Wroblewski, M. Blanca Piazuelo, Uma Krishna, Giovanni Suarez, Judith Romero-Gallo, Alberto G. Delgado, Richard M. Peek

Summary: In this study, a novel mechanism was identified through which H. pylori actively suppresses STING and RIG-I signaling via downregulation of IRF3 activation, which not only regulates the initial innate immune response, but also drives chronic gastric inflammation and injury.

GUT MICROBES (2022)

Article Biochemistry & Molecular Biology

Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance

Martina Radic, Ignacija Vlasic, Maja Jazvinscak Jembrek, Andela Horvat, Ana Tadijan, Maja Sabol, Marko Duzevic, Maja Herak Bosnar, Neda Slade

Summary: Despite the advancements in melanoma treatment, many patients still develop resistance to drugs, such as the RAF inhibitor vemurafenib. In this study, researchers generated and examined two melanoma-derived cell lines with acquired resistance to vemurafenib. They found that the resistant cells displayed features of epithelial-mesenchymal transition (EMT) and exhibited a hybrid phenotype. Surprisingly, the resistant cells showed decreased migration ability but had a tendency for collective migration. Signaling pathway analysis revealed reactivation of MAPK and activation of the PI3K/AKT pathway in the vemurafenib-resistant cells. The acquired resistance also led to resistance to chemotherapy in the primary melanoma cells. Further investigation is needed to understand the negative regulators of NME proteins in vemurafenib resistance and their impact on PI3K/AKT signaling and melanoma cell characteristics.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Research & Experimental

Iron deficiency linked to altered bile acid metabolism promotes Helicobacter pylori-induced inflammation-driven gastric carcinogenesis

Jennifer M. Noto, M. Blanca Piazuelo, Shailja C. Shah, Judith Romero-Gallo, Jessica L. Hart, Chao Di, James D. Carmichael, Alberto G. Delgado, Alese E. Halvorson, Robert A. Greevy, Lydia E. Wroblewski, Ayushi Sharma, Annabelle B. Newton, Margaret M. Allaman, Keith T. Wilson, M. Kay Washington, M. Wade Calcutt, Kevin L. Schey, Bethany P. Cummings, Charles R. Flynn, Joseph P. Zackular, Richard M. Peek

Summary: This study reveals that Helicobacter pylori enhances gastric injury under conditions of iron deficiency and that this phenomenon is closely associated with altered bile acid metabolism. Deoxycholic acid (DCA) is identified as a carcinogenic bile acid that can further exacerbate gastric injury and promote the translocation of the H. pylori oncoprotein CagA into host cells. Conversely, the use of bile acid sequestrants can attenuate H. pylori-induced injury. Furthermore, cumulative use of bile acid sequestrants is significantly associated with a reduced risk of gastric cancer in human populations. These findings demonstrate the importance of bile acid metabolism in H. pylori-induced gastric injury and carcinogenesis.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Oncology

p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies

Andela Horvat, Ana Tadijan, Ignacija Vlasic, Neda Slade

Summary: The p53 family members, including p53, p63, and p73, play crucial roles in carcinogenesis, particularly in colorectal carcinoma. They have the ability to form tetramers that activate the transcription of specific genes, making them potential targets for cancer treatment. Understanding the interactions and activities of the p53 family members can contribute to the development of new targeted therapies for cancer.

CANCERS (2021)

Meeting Abstract Gastroenterology & Hepatology

REGULATION OF P14ARF TUMOR SUPPRESSOR BY HELICOBACTER PYLORI IN GASTRIC EPITHELIAL CELLS

Andela Horvat, Balamurugan Ramatchandirin, Jennifer M. Noto, Wael M. El-Rifai, Richard M. Peek, Alexander Zaika

GASTROENTEROLOGY (2018)

No Data Available